Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (GENIL) - Total Liabilities

Latest as of September 2025: TL7.52 Billion TRY ≈ $168.49 Million USD

Based on the latest financial reports, Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (GENIL) has total liabilities worth TL7.52 Billion TRY (≈ $168.49 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check GENIL asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS - Total Liabilities Trend (2018–2024)

This chart illustrates how Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see GENIL asset base.

Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS Competitors by Total Liabilities

The table below lists competitors of Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS ranked by their total liabilities.

Company	Country	Total Liabilities
Day One Biopharmaceuticals Inc NASDAQ:DAWN	USA	$62.91 Million
Bombay Burmah Trading Corporation Limited NSE:BBTC	India	Rs60.62 Billion
Genco Shipping & Trading Ltd NYSE:GNK	USA	$365.01 Billion
Shandong Hi-Speed Road&Bridge SHE:000498	China	CN¥135.60 Billion
Blue Square Real Estate Ltd TA:BLSR	Israel	ILA8.21 Billion
Tianjin You Fa Steel Pipe Group Stock Co Ltd SHG:601686	China	CN¥19.30 Billion
NeoGenomics Inc NASDAQ:NEO	USA	$517.77 Million
Sinar Mas Agro Resources and Technology Tbk PT JK:SMAR	Indonesia	Rp24.52 Trillion

Liability Composition Analysis (2018–2024)

This chart breaks down Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Gen Ilac ve Saglik Urunleri Sanayi ve Ti (GENIL) balance sheet quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.35	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.77	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.44	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (2018–2024)

The table below shows the annual total liabilities of Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS from 2018 to 2024.

Year	Total Liabilities	Change
2024-12-31	TL5.00 Billion ≈ $112.05 Million	+21.43%
2023-12-31	TL4.12 Billion ≈ $92.28 Million	+369.32%
2022-12-31	TL877.88 Million ≈ $19.66 Million	+5.11%
2021-12-31	TL835.20 Million ≈ $18.71 Million	+60.34%
2020-12-31	TL520.88 Million ≈ $11.67 Million	+65.49%
2019-12-31	TL314.75 Million ≈ $7.05 Million	+4.91%
2018-12-31	TL300.03 Million ≈ $6.72 Million	--

About Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS

IS:GENIL Turkey Drug Manufacturers - Specialty & Generic

Market Cap

$1.13 Billion

TL50.40 Billion TRY

Market Cap Rank

#8452 Global

#66 in Turkey

Share Price

TL11.20

Change (1 day)

+3.61%

52-Week Range

TL7.17 - TL216.90

All Time High

TL216.90